Naked Shorts at the Supreme Court Dec 1, 2015 2:00 PM

New Post Public Reply Private Reply Replies (0) Message Board
AlanC AlanC #3435
Naked Shorts at the Supreme Court

Dec 1, 2015 2:00 PM EST

By Noah Feldman

When you’re trading securities, you generally think about being regulated by the Securities and Exchange Commission and federal law. Should you be worried about state law, too? That question isn't merely theoretical, as shown by the naked short selling case that was argued Tuesday before the U.S. Supreme Court. The answer has practical consequences for traders of all kinds.

The case, Merrill Lynch v. Manning, arises from allegations by individual shareholders in Escala Group Inc., that traders at Merrill Lynch, Knight Equity Markets and UBS Securities, among others, engaged in naked short selling to manipulate the value of the stock. In essence, the original plaintiffs alleged that the traders made short sales without bothering to borrow the securities that would be needed to cover the trade.

That's illegal -- sort of. No federal or state law directly criminalizes naked short selling. However, an SEC rule called Regulation SHO says a broker-dealer must have “reasonable grounds” to believe that it could borrow and deliver the security within three days. If the broker-dealer fails to deliver for 13 days, the regulation imposes a “close out” duty to purchase and deliver securities “of like kind and quantity.”

Given that federal law doesn't obviously impose a clear form of liability for naked short selling, the plaintiffs in the case went to New Jersey state court instead. They alleged violations of the state's RICO law, the one designed to outlaw conspiracies of the kind traditionally used by organized crime. RICO laws require specification of particular legal violations; the plaintiffs said the defendants had committed acts of securities fraud and theft under New Jersey law. For good measure, they also said the defendants were liable under New Jersey’s unwritten common law for breach of contract, negligence and other assorted claims.

To explain to the state court what the broker-dealers had done wrong, the plaintiffs described federal Regulation SHO, which they said the defendants had violated. But they were careful to say that their state law case didn't depend on there being a violation of the federal regulation.

Lawyers for Merrill Lynch and the other defendants did what any lawyer would’ve done under the circumstances: They sought to move the case to federal court, where they’d be able to argue that federal law controls naked short selling and that they hadn’t broken it. A federal district court said the case belonged in federal court. But the U.S. Court of Appeals for the 3rd Circuit disagreed, and the case ended up before the Supreme Court.

Who's right? The best argument for allowing the case to go forward in state court is that state securities regulations have been around since long before there was an SEC. The Securities Exchange Act of 1933 was famously drafted over the weekend of April 8, 1933, in a hotel room by the dream team of Thomas Corcoran, Benjamin Cohen and James Landis, three brilliant students of Felix Frankfurter who followed his marching orders in drafting legislation for Franklin Roosevelt’s administration.

By then, every state but Nevada had enacted some version of a general law prohibiting deceptive securities practices. These state laws are called “blue sky laws,” because, as the Supreme Court put it in 1917, they outlaw “speculative schemes which have no more basis than so many feet of ‘blue sky.’”

Congress never said that it was displacing the states’ blue sky laws, which strongly implies that it should still be possible to go to state court in a securities case where federal law doesn’t cover the precise situation.

The strongest counterargument is that it’s highly inefficient to subject securities regulation to the laws of 50 states plus federal law. A national industry requires national standards. Compliance costs are high enough without requiring broker-dealers to worry about divergent regulations in different places.

What makes it tricky to predict the outcome in this case is that the usual liberal and conservative positions produce contradiction.

Generally, the liberals on today’s court like centralized national regulation and favor federal law. So you’d expect them to want to say that this is a federal issue that belongs in federal court.

But that would be a pro-defendant ruling in this case, because Merrill Lynch and the other defendants would probably get a more sympathetic hearing from a federal court, which could find they aren’t liable under federal law. That’s awkward for the liberals, because it makes them look soft on stock manipulators. It also makes them look as if they’re siding with the banks against the little guy, which the liberals hate to do.

For the conservatives, the problem is that respecting state law, the federalist position, puts them in a position of helping pesky plaintiffs’ lawyers who, conservatives believe, are trying to harass defendants for money. The court’s conservatives dislike and distrust plaintiffs’ side securities lawyers, and won’t want to give them the tool of going to state court. They think such litigation adds costs and inefficiency without improving securities markets.

Given the dual tension, my instinct is that the conservatives will win and the lawsuit will be allowed to go forward. But this one will be close -- so call your compliance officer today. He or she may be your best friend.

This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.

To contact the author of this story:
Noah Feldman at nfeldman7@bloomberg.net


http://www.bloombergview.com/articles/2015-12...reme-court
Thanks to 7/10/11 for this one!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

53% of European Telecom Users Eye Provider Switch

Updated Category News Views 2

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 1

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 4

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 14

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause

Updated Category News Views 0

Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading

Top 5 Most Recently Viewed Articles

MongoDB Reports Exceptional Earnings, Boosting Investor Confidence

Updated Category News Views 117

MongoDB's Remarkable Growth Continues MongoDB Inc (NASDAQ: MDB) has become the talk of the town as its shares soar following stellar earnings results that have impressed investors and analysts alike. The recent financial report showcased not just revenue growth but also a promising outlook that has captivated the attention of the market. Investors are keenly watching the...

Continue Reading
Federal Judge's Ruling on Trump's Workforce Watchdog Dismissal

Updated Category News Views 186

Federal Judge's Decision on Trump’s Actions A recent ruling from a federal judge has highlighted the legality of President Donald Trump's dismissal attempts regarding a federal workforce watchdog. This ruling not only affects Trump but also serves as a significant precedent in maintaining the independence of the Office of Special Counsel. Details of the Case Judge Amy...

Continue Reading
Gables Residential Celebrates ESG Commitment with Award Success

Updated Category News Views 188

Gables Residential Earns Esteemed Recognition for ESG Leadership Gables Residential, a recognized leader in the multifamily development and management sector, has achieved a remarkable milestone by receiving the Multi-Housing News (MHN) Excellence Gold Award. This accolade celebrates the company’s dedicated efforts toward Environmental, Social, and Governance (ESG)...

Continue Reading
Microsoft's Layoffs Spark Controversy Over AI Support

Updated Category News Views 221

Layoffs at Microsoft Prompt AI Support Discussion Microsoft Corporation (NASDAQ: MSFT) recently faced a crisis as it laid off approximately 9,100 employees, a move that set off a ripple effect of reactions within the tech community. The company's decision comes as it continues to streamline operations amid economic pressures. In the wake of these layoffs, feedback from an...

Continue Reading
Caris Life Sciences to Present Groundbreaking Research at ESMO 2024

Updated Category News Views 154

Caris Life Sciences to Present Innovative Research at ESMO 2024 Caris Life Sciences (Caris), in partnership with prominent cancer centers, is preparing to unveil significant research findings that highlight the clinical benefits of comprehensive molecular profiling at the European Society for Medical Oncology (ESMO) Congress 2024. The research will cover seven studies...

Continue Reading